Cognitive decline

Cognitive decline, encompassing conditions such as dementia and Alzheimer’s disease, represents a growing public health challenge with profound social and economic consequences. As populations age worldwide, the prevalence of cognitive impairment is expected to rise sharply, straining healthcare systems, families, and communities. Beyond direct health impacts, cognitive decline affects workforce participation, caregiving demands, and quality of life for both patients and caregivers.

The risks are multidimensional, influenced by genetic, lifestyle, and environmental factors, as well as broader social determinants such as education and socioeconomic status. Policy-makers face pressure to prepare healthcare systems for rising caseloads, while researchers and clinicians work to better understand prevention, detection, and treatment. Public concern often centers on early signs of decline, the costs of care, and the emotional toll on families.

Risk sciences play a valuable role in clarifying patterns, identifying risk factors, and evaluating interventions. Through epidemiological studies, risk modeling, and health impact assessments, risk sciences can inform evidence-based strategies to prevent or delay onset, improve care delivery, and allocate resources more effectively. Risk communication is also key, ensuring that information is conveyed with sensitivity, accuracy, and clarity.

RSI is dedicated to supporting stakeholders in addressing cognitive decline, bringing expertise and experience to this critical area of health risk.